The star life sciences litigator appears to be earning his keep. On Thursday, he and Kirkland partner Andrew Kassof co-led a trial team that delivered a blockbuster win on behalf of Abbott Laboratories in Dallas federal court, with George Bramblett of Haynes and Boone as co-counsel.
With more than $1 billion on the line, Abbott was accused of violating the False Claims Act by submitting more than 35,000 improper claims to Medicare.
After a three-week trial, it took the jury just three hours to find for Abbott across the board.
For Hurst, who declined comment, the win follows a $94 million verdict on behalf of AbbVie Inc. against MedImmune LLC in September, and a successful patent challenge on behalf of Hospira Inc. against Merck & Co. in November.
Colquitt’s whistleblower suit focused on bile duct stents, which are intended as short-term, palliative relief for people who have pancreatic or bile duct cancer, and who usually die within a year. Abbott acquired Guidant’s stent business in 2006.
Excerpted from the AmLaw Litigation Daily. To read the full article, please click here (subscription required).